JP2011225581A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011225581A5 JP2011225581A5 JP2011123144A JP2011123144A JP2011225581A5 JP 2011225581 A5 JP2011225581 A5 JP 2011225581A5 JP 2011123144 A JP2011123144 A JP 2011123144A JP 2011123144 A JP2011123144 A JP 2011123144A JP 2011225581 A5 JP2011225581 A5 JP 2011225581A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- therapeutic agent
- prophylactic
- agent according
- opg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38954599A | 1999-09-03 | 1999-09-03 | |
| US09/389,545 | 1999-09-03 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001521333A Division JP2003508491A (ja) | 1999-09-03 | 2000-08-18 | 癌および癌に関連する骨損失の予防または治療のための組成物および方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011225581A JP2011225581A (ja) | 2011-11-10 |
| JP2011225581A5 true JP2011225581A5 (https=) | 2013-10-24 |
Family
ID=23538715
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001521333A Withdrawn JP2003508491A (ja) | 1999-09-03 | 2000-08-18 | 癌および癌に関連する骨損失の予防または治療のための組成物および方法 |
| JP2011123144A Pending JP2011225581A (ja) | 1999-09-03 | 2011-06-01 | 癌および癌に関連する骨損失の予防または治療のための組成物および方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001521333A Withdrawn JP2003508491A (ja) | 1999-09-03 | 2000-08-18 | 癌および癌に関連する骨損失の予防または治療のための組成物および方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20060019887A1 (https=) |
| EP (2) | EP1140136B1 (https=) |
| JP (2) | JP2003508491A (https=) |
| KR (1) | KR20010085996A (https=) |
| CN (1) | CN1345246A (https=) |
| AT (1) | ATE362374T1 (https=) |
| AU (1) | AU6788900A (https=) |
| CA (1) | CA2349406C (https=) |
| DE (1) | DE60034871T2 (https=) |
| ES (1) | ES2287028T3 (https=) |
| HU (1) | HUP0104688A3 (https=) |
| IL (1) | IL142900A0 (https=) |
| WO (1) | WO2001017543A2 (https=) |
| ZA (1) | ZA200103565B (https=) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL117175A (en) | 1995-02-20 | 2005-11-20 | Sankyo Co | Osteoclastogenesis inhibitory factor protein |
| DE69740107D1 (de) | 1996-12-23 | 2011-03-10 | Immunex Corp | Rezeptor aktivator von nf-kappa b, rezeptor is mitglied der tnf rezeptor superfamilie |
| ES2263204T5 (es) | 1997-04-15 | 2013-10-14 | Daiichi Sankyo Company, Limited | Nueva proteína y proceso para producir la misma |
| ES2284203T5 (es) | 1997-04-16 | 2016-03-11 | Amgen Inc. | Proteínas de unión a osteoprotegerina y sus receptores |
| US6316408B1 (en) | 1997-04-16 | 2001-11-13 | Amgen Inc. | Methods of use for osetoprotegerin binding protein receptors |
| AU762574B2 (en) | 1998-05-14 | 2003-06-26 | Immunex Corporation | Method of inhibiting osteoclast activity |
| HUP0104126A3 (en) * | 1998-10-28 | 2004-07-28 | Sankyo Company Ltd Chuo Ku | Remedies for bone metabolic errors |
| US20020090646A1 (en) * | 2000-05-03 | 2002-07-11 | Amgen Inc. | Calcitonin-related molecules |
| WO2002024896A2 (en) | 2000-09-22 | 2002-03-28 | Immunex Corporation | Screening assays for agonists or antagonists of receptor activat or of nf-kb |
| MXPA03011270A (es) * | 2001-06-06 | 2004-03-18 | Immunex Corp | Uso de antagonistas rank para tratar cancer. |
| EP1270015A3 (en) * | 2001-06-29 | 2004-02-25 | Sankyo Company Limited | A complex comprising OCIF and Polysaccharide |
| US7718776B2 (en) | 2002-04-05 | 2010-05-18 | Amgen Inc. | Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors |
| US7585840B2 (en) | 2002-04-10 | 2009-09-08 | Merck Serono S.A. | Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease |
| EP1515743A2 (en) | 2002-04-10 | 2005-03-23 | Applied Research Systems ARS Holding N.V. | Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis |
| CA2487428A1 (en) * | 2002-06-07 | 2003-12-18 | Trillium Therapeutics Inc. | Cd200-receptor mediated modulation of bone development |
| BRPI0519008A2 (pt) * | 2004-12-13 | 2008-12-23 | Evogenix Ltd | proteÍnas variantes de osteoprotegerina |
| TW200714289A (en) * | 2005-02-28 | 2007-04-16 | Genentech Inc | Treatment of bone disorders |
| ES2699077T3 (es) * | 2009-06-12 | 2019-02-07 | Sunovion Pharmaceuticals Inc | Apomorfina sublingual |
| CN102242209B (zh) * | 2011-07-05 | 2013-12-11 | 北京大学人民医院 | 基于多个基因辅助诊断多发性骨髓瘤患者的定量检测试剂盒 |
| AU2012375257B2 (en) * | 2012-03-31 | 2019-09-12 | R-Pharm International, Limited Liability Company | Osteoprotegerin derived composition and use thereof |
| KR20160127824A (ko) * | 2014-03-06 | 2016-11-04 | 알-팜 오버씨즈, 인코포레이티드 | 오스테오프로테게린 유래의 rankl 억제제 |
| KR101576904B1 (ko) * | 2014-07-31 | 2015-12-14 | (주)케어젠 | 파골세포 분화 및 활성 억제능을 갖는 펩타이드 및 이의 용도 |
| EP3535585A1 (en) * | 2016-11-04 | 2019-09-11 | Aarhus Universitet | Identification and treatment of tumors characterized by an overexpression of the neonatal fc receptor |
| CN110483647B (zh) * | 2019-08-19 | 2021-02-09 | 重庆大学附属肿瘤医院 | 一种抗肿瘤多肽及其应用 |
| JP2023525960A (ja) * | 2020-04-15 | 2023-06-20 | セラダプティブ インク | 骨に標的治療薬を送達するための組成物および方法 |
| KR20230118573A (ko) * | 2020-11-11 | 2023-08-11 | 에이치큐 한 | 액티빈/tgf-베타 및 rankl의 이작용성 길항제 및 이의 용도 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| US4710473A (en) * | 1983-08-10 | 1987-12-01 | Amgen, Inc. | DNA plasmids |
| AU610083B2 (en) * | 1986-08-18 | 1991-05-16 | Clinical Technologies Associates, Inc. | Delivery systems for pharmacological agents |
| FR2640537B1 (fr) * | 1988-12-21 | 1992-02-21 | Levy Guy | Installation et procede utilisant l'effet laser, pour la coupe ou la vaporisation de materiaux et tissus divers |
| US5013556A (en) * | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| JP3507486B2 (ja) * | 1991-03-15 | 2004-03-15 | アムジエン・インコーポレーテツド | 顆粒球コロニー刺激因子の肺内投与 |
| US5447851B1 (en) * | 1992-04-02 | 1999-07-06 | Univ Texas System Board Of | Dna encoding a chimeric polypeptide comprising the extracellular domain of tnf receptor fused to igg vectors and host cells |
| ATE311895T1 (de) * | 1992-05-26 | 2005-12-15 | Immunex Corp | Neue zytokine die cd30 binden |
| US5457035A (en) * | 1993-07-23 | 1995-10-10 | Immunex Corporation | Cytokine which is a ligand for OX40 |
| US5843901A (en) * | 1995-06-07 | 1998-12-01 | Advanced Research & Technology Institute | LHRH antagonist peptides |
| US20050147611A1 (en) * | 1995-12-22 | 2005-07-07 | Amgen Inc. | Combination therapy for conditions leading to bone loss |
| US20030207827A1 (en) * | 1995-12-22 | 2003-11-06 | William J. Boyle | Osteoprotegerin |
| US6369027B1 (en) * | 1995-12-22 | 2002-04-09 | Amgen Inc. | Osteoprotegerin |
| US6613544B1 (en) * | 1995-12-22 | 2003-09-02 | Amgen Inc. | Osteoprotegerin |
| US7005413B1 (en) * | 1995-12-22 | 2006-02-28 | Amgen Inc. | Combination therapy for conditions leading to bone loss |
-
2000
- 2000-08-18 IL IL14290000A patent/IL142900A0/xx unknown
- 2000-08-18 JP JP2001521333A patent/JP2003508491A/ja not_active Withdrawn
- 2000-08-18 ES ES00955737T patent/ES2287028T3/es not_active Expired - Lifetime
- 2000-08-18 AT AT00955737T patent/ATE362374T1/de not_active IP Right Cessation
- 2000-08-18 KR KR1020017005606A patent/KR20010085996A/ko not_active Ceased
- 2000-08-18 AU AU67889/00A patent/AU6788900A/en not_active Abandoned
- 2000-08-18 HU HU0104688A patent/HUP0104688A3/hu unknown
- 2000-08-18 EP EP00955737A patent/EP1140136B1/en not_active Expired - Lifetime
- 2000-08-18 CN CN00802472A patent/CN1345246A/zh active Pending
- 2000-08-18 WO PCT/US2000/022806 patent/WO2001017543A2/en not_active Ceased
- 2000-08-18 CA CA2349406A patent/CA2349406C/en not_active Expired - Fee Related
- 2000-08-18 DE DE60034871T patent/DE60034871T2/de not_active Expired - Lifetime
- 2000-08-18 EP EP06022155A patent/EP1800691A3/en not_active Withdrawn
-
2001
- 2001-05-03 ZA ZA200103565A patent/ZA200103565B/en unknown
-
2004
- 2004-09-22 US US10/948,053 patent/US20060019887A1/en not_active Abandoned
-
2011
- 2011-06-01 JP JP2011123144A patent/JP2011225581A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011225581A5 (https=) | ||
| JP7493569B2 (ja) | 癌を処置するためのリルゾール、リルゾールプロドラッグまたはリルゾール類似体と免疫療法との併用 | |
| CA2349406A1 (en) | Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer | |
| JP4206272B2 (ja) | 組織炎症及び発癌を治療するためのグアニル酸シクラーゼ受容体アゴニスト | |
| CA2480099C (en) | Erbb3 based methods and compositions for treating neoplasms | |
| ES2633453T3 (es) | Constructos de fusión de dominios líticos y métodos de preparación y utilización de los mismos | |
| ES2758881T3 (es) | Agentes de unión selectiva antagonistas de proteína que se une a osteoprotegerina | |
| WO2022234852A1 (ja) | 環状ペプチド化合物の医薬用途 | |
| JP2014521684A5 (https=) | ||
| EA020466B1 (ru) | Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний | |
| JP2010529026A5 (https=) | ||
| CN104684579A (zh) | 单特异性的和双特异性的抗-IGF-1R 和抗-ErbB3 抗体的剂量和施用 | |
| JP2012500001A5 (https=) | ||
| JP7374765B2 (ja) | 抗ｄｋｋ－１抗体を使用して癌を治療するためのバイオマーカーとしてのベータ－カテニンの使用 | |
| MX2013015333A (es) | Anticuerpos anti-erbb3 en combinación con paclitaxel para el tratamiento de cánceres ginecológgicos. | |
| CN104017049B (zh) | 一种肿瘤特异性靶向多肽及其应用 | |
| CN100422211C (zh) | 抑制igf-i和-ii的gh-rh拮抗性相似物 | |
| EP1653992A1 (en) | Use of a vegf antagonist in combination with radiation therapy | |
| JP2021516222A (ja) | 副甲状腺ホルモンポリペプチドコンジュゲートおよびその使用方法 | |
| Xu et al. | New agonist-and antagonist-based treatment approaches for advanced prostate cancer | |
| CN116406274B (zh) | 用于治疗冠状病毒的cd3抗体 | |
| US20140322306A1 (en) | Medical Use | |
| JP2021523096A5 (https=) | ||
| TW201919684A (zh) | 用於治療肺癌及其他癌症的腫瘤相關增殖肽與相關抗癌免疫原組成物 | |
| JP2021523931A5 (https=) |